国际联盟与AGREE评估:71部COVID-19重症患者管理临床实践指南的活体系统评价
该活体系统评价检索2019年11月至2020年11月多个数据库及灰色文献,纳入71部COVID-19重症患者管理临床实践指南,用AGREE II工具评估质量。六个领域平均得分分别为范围和目的65%、利益相关方参与39%、制定的严谨性27%、表述清晰性70%、适用性26%、编辑独立性42%,多数指南总体质量低(低于40%)。结论认为未来COVID-19指南制定需依赖标准循证方法与工具。
要点
- 共纳入71部COVID-19重症患者管理指南,多数总体质量低(低于40%)。
- AGREE II各领域平均得分:范围和目的65%、利益相关方参与39%、制定的严谨性27%、表述清晰性70%、适用性26%、编辑独立性42%。
- 未来COVID-19指南制定需依赖标准循证方法与工具。
核心结论
- 未来COVID-19指南制定需依赖标准循证方法与工具。
研究设计与样本
- 活体系统评价,检索Medline、CINAHL、EMBASE、CNKI、CBM、WanFang及灰色文献,时间范围为2019年11月至2020年11月,无语言限制。
- 由一名评价者独立筛选标题和摘要,第二名评价者确认决定;全文由两名评价者独立双份评估,分歧通过共识解决。
- 纳入任何提供COVID-19重症患者管理推荐的指南,数据由两名评价者独立双份提取,描述性总结指南特征,用AGREE II工具评估质量并总结相关治疗干预。
主要发现
- 共检索到3907条记录,纳入71部临床实践指南。
- AGREE II六个领域平均得分(标准差)分别为:范围和目的65%(SD19.56%)、利益相关方参与39%(SD19.64%)、制定的严谨性27%(SD19.48%)、表述清晰性70%(SD15.74%)、适用性26%(SD18.49%)、编辑独立性42%(SD34.91%)。
- 多数指南总体质量低(低于40%)。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: We aimed to systematically identify and critically assess the clinical practice guidelines (CPGs) for the management of critically ill patients with COVID-19 with the AGREE II instrument. STUDY DESIGN AND SETTING: We searched Medline, CINAHL, EMBASE, CNKI, CBM, WanFang, and grey literature from November 2019 - November 2020. We did not apply language restrictions. One reviewer independently screened the retrieved titles and abstracts, and a second reviewer confirmed the decisions. Full texts were assessed independently and in duplicate. Disagreements were resolved by consensus. We included any guideline that provided recommendations on the management of critically ill patients with COVID-19. Data extraction was performed independently and in duplicate by two reviewers. We descriptively summarized CPGs characteristics. We assessed the quality with the AGREE II instrument and we summarized relevant therapeutic interventions. RESULTS: We retrieved 3,907 records and 71 CPGs were included. Means (Standard Deviations) of the scores for the 6 domains of the AGREE II instrument were 65%(SD19.56%), 39%(SD19.64%), 27%(SD19.48%), 70%(SD15.74%), 26%(SD18.49%), 42%(SD34.91) for the scope and purpose, stakeholder involvement, rigor of development, clarity of presentation, applicability, editorial independence domains, respectively. Most of the CPGs showed a low overall quality (less than 40%). CONCLUSION: Future CPGs for COVID-19 need to rely, for their development, on standard evidence-based methods and tools.
引用
- Amer YS, Titi MA, Godah MW, et al. International alliance and AGREE-ment of 71 clinical practice guidelines on the management of critical care patients with COVID-19: a living systematic review. J Clin Epidemiol. 2021. PMID: 34785346. doi:10.1016/j.jclinepi.2021.11.010
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。